Skip to main content
. 2016 Jul 2;2016(7):CD010832. doi: 10.1002/14651858.CD010832.pub2

3.13. Analysis.

Comparison 3 FLUPHENAZINE (ORAL) vs QUETIAPINE, Outcome 13 Adverse effects: 4b. Other ‐ average endpoint weight loss (average weight in kg) (skewed).

Adverse effects: 4b. Other ‐ average endpoint weight loss (average weight in kg) (skewed)
Study Intervention Mean(kg) SD N
short term (up to 12 weeks)
Conley 2005 Fluphenazine ‐2.6 5.7 13
Conley 2005 Risperidone ‐0.65 2.43 13